Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Scacciatella

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Giornale Italiano Di Cardiologia (2006)|January 21, 2011
[Current perspectives in cell therapy in cardiology: an overview of ongoing trials]Paolo Scacciatella, Gianluca Amato, Elisa Ebrille, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 22, 2011
Percutaneous coronary interventions with an endothelial progenitor cell capture stent (EPC) for high risk patients with no option for drug eluting stents: long term clinical outcomes of a single centre registryPaolo Scacciatella, Emanuele Meliga, Maurizio D'Amico, et al.
The American Journal of Emergency Medicine|September 18, 2012
Pulmonary hemorrhage and acute pulmonary thromboembolism after abciximab administrationFederico Conrotto, Paolo Scacciatella, Tullio Usmiani, et al.
Cytokine|May 16, 2006
Combined administration of G-CSF and GM-CSF stimulates monocyte-derived pro-angiogenic cells in patients with acute myocardial infarctionStefania Bruno, Benedetta Bussolati, Paolo Scacciatella, et al.
Giornale Italiano Di Cardiologia (2006)|September 28, 2011
[Feasibility and safety of same-day discharge after percutaneous coronary intervention with femoral access and AngioSeal closure device: a single-center experience]Mauro Pennone, Maurizio D'Amico, Valeria Frisenda, et al.
Stem Cells International|January 30, 2018
Cell Therapy for Refractory Angina: A ReappraisalBeatrice Bassetti, Patrizia Nigro, Valentina Catto, et al.
Stem Cells and Development|July 12, 2014
The CD133+ cell as advanced medicinal product for myocardial and limb ischemiaDario Bongiovanni, Beatrice Bassetti, Elisa Gambini, et al.
BMC Cardiovascular Disorders|January 25, 2020
Anticoagulant and anti-thrombotic therapy in acute type B aortic dissection: when real-life scenarios face the shadows of the evidence-based medicinePier Paolo Bocchino, Ovidio De Filippo, Francesco Piroli, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 25, 2015
Recurrent cerebral ischemia after patent foramen ovale percutaneous closure in older patients: A two-center registry studyPaolo Scacciatella, Ilaria Meynet, Patrizia Presbitero, et al.
JACC. Case Reports|May 8, 2023
Use of Taurolidine in a Patient With a Cardiac Implantable Electronic Device ProtrusionMarcello Giudice, Bruna Catuzzo, Nicola Berlier, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Giornale Italiano Di Cardiologia (2006)|January 21, 2011
[Current perspectives in cell therapy in cardiology: an overview of ongoing trials]Paolo Scacciatella, Gianluca Amato, Elisa Ebrille, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 22, 2011
Percutaneous coronary interventions with an endothelial progenitor cell capture stent (EPC) for high risk patients with no option for drug eluting stents: long term clinical outcomes of a single centre registryPaolo Scacciatella, Emanuele Meliga, Maurizio D'Amico, et al.
The American Journal of Emergency Medicine|September 18, 2012
Pulmonary hemorrhage and acute pulmonary thromboembolism after abciximab administrationFederico Conrotto, Paolo Scacciatella, Tullio Usmiani, et al.
Cytokine|May 16, 2006
Combined administration of G-CSF and GM-CSF stimulates monocyte-derived pro-angiogenic cells in patients with acute myocardial infarctionStefania Bruno, Benedetta Bussolati, Paolo Scacciatella, et al.
Giornale Italiano Di Cardiologia (2006)|September 28, 2011
[Feasibility and safety of same-day discharge after percutaneous coronary intervention with femoral access and AngioSeal closure device: a single-center experience]Mauro Pennone, Maurizio D'Amico, Valeria Frisenda, et al.
Stem Cells International|January 30, 2018
Cell Therapy for Refractory Angina: A ReappraisalBeatrice Bassetti, Patrizia Nigro, Valentina Catto, et al.
Stem Cells and Development|July 12, 2014
The CD133+ cell as advanced medicinal product for myocardial and limb ischemiaDario Bongiovanni, Beatrice Bassetti, Elisa Gambini, et al.
BMC Cardiovascular Disorders|January 25, 2020
Anticoagulant and anti-thrombotic therapy in acute type B aortic dissection: when real-life scenarios face the shadows of the evidence-based medicinePier Paolo Bocchino, Ovidio De Filippo, Francesco Piroli, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 25, 2015
Recurrent cerebral ischemia after patent foramen ovale percutaneous closure in older patients: A two-center registry studyPaolo Scacciatella, Ilaria Meynet, Patrizia Presbitero, et al.
JACC. Case Reports|May 8, 2023
Use of Taurolidine in a Patient With a Cardiac Implantable Electronic Device ProtrusionMarcello Giudice, Bruna Catuzzo, Nicola Berlier, et al.
Pageof 6